Evidence map›Paper›PMID 27991488›Full record

ArticleNature communications2016

A neuronal network of mitochondrial dynamics regulates metastasis.

M Cecilia Caino, Jae Ho Seo, Angeline Aguinaldo, Eric Wait, Kelly G Bryant, Andrew V Kossenkov, James E Hayden, Valentina Vaira, Annamaria Morotti, Stefano Ferrero and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Dysregulation of Mitochondrial Function in Cancer Cells.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

M Cecilia CainoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Jae Ho SeoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Angeline AguinaldoDepartment of Electrical and Computer Engineering, Drexel University College of Engineering, Philadelphia, Pennsylvania 19104, USA.
Eric WaitDepartment of Electrical and Computer Engineering, Drexel University College of Engineering, Philadelphia, Pennsylvania 19104, USA.
Kelly G BryantProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Andrew V KossenkovCenter for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
James E HaydenImaging Shared Resource, The Wistar Institute Cancer Center, Philadelphia, Pennsylvania 19104, USA.
Valentina VairaIstituto Nazionale Genetica Molecolare 'Romeo and Enrica Invernizzi', Milan 20122, Italy.ORCID 0000-0003-4416-6216
Annamaria MorottiDivision of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy.ORCID 0000-0002-4247-4365
Stefano FerreroDivision of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy.
Silvano BosariDivision of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy.ORCID 0000-0002-9744-6951
Dmitry I GabrilovichProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Lucia R LanguinoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Andrew R CohenDepartment of Electrical and Computer Engineering, Drexel University College of Engineering, Philadelphia, Pennsylvania 19104, USA.
Dario C AltieriProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Role of Runx2 in prostate tumorigenesis and metastasisP01CA140043 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2010 to 2021
$12.2M
CONTROL OF APOPTOSIS IN CANCER BY SURVIVINR01CA078810 · NCI · YALE UNIVERSITY · PI ALTIERI, DARIO C · 1998 to 2017
$5.5M
INTEGRIN SIGNALING PATHWAYS IN PROSTATE CANCERR01CA089720 · NCI · YALE UNIVERSITY · PI LANGUINO, LUCIA R. · 2001 to 2014
$2.8M
Analyzing Neural Stem Cell Clonal DevelopmentR01NS076709 · NINDS · UNIVERSITY OF WISCONSIN MILWAUKEE · PI COHEN, ANDREW ROBERT · 2011 to 2015
$1.7M
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center LevelR50CA211199 · NCI · WISTAR INSTITUTE · PI Andrew V Kossenkov · 2016 to 2026
$1.6M
(PQC2) Plasticity Of The.PI3K Network In Early DormancyR01CA190027 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2014 to 2016
$1.2M
Mitochondrial Hsp90s Regulation of Tumor Bioenergetics and MetastasisF32CA177018 · NCI · WISTAR INSTITUTE · PI CAINO, MARIA CECILIA · 2013 to 2015
$171k
NCI NIH HHS F32 CA177018NCI NIH HHS P01 CA140043NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA078810NCI NIH HHS R01 CA089720NCI NIH HHS R01 CA190027NCI NIH HHS R50 CA211199NCI NIH HHS T32 CA009171NINDS NIH HHS R01 NS076709
6 · The paper itself

Abstract

The role of mitochondria in cancer is controversial. Using a genome-wide shRNA screen, we now show that tumours reprogram a network of mitochondrial dynamics operative in neurons, including syntaphilin (SNPH), kinesin KIF5B and GTPase Miro1/2 to localize mitochondria to the cortical cytoskeleton and power the membrane machinery of cell movements. When expressed in tumours, SNPH inhibits the speed and distance travelled by individual mitochondria, suppresses organelle dynamics, and blocks chemotaxis and metastasis, in vivo. Tumour progression in humans is associated with downregulation or loss of SNPH, which correlates with shortened patient survival, increased mitochondrial trafficking to the cortical cytoskeleton, greater membrane dynamics and heightened cell invasion. Therefore, a SNPH network regulates metastatic competence and may provide a therapeutic target in cancer.

Indexed as

Down-RegulationGene Expression Regulation, NeoplasticHumansKinesinsMembrane ProteinsMetabolic Networks and PathwaysMitochondrial DynamicsMitochondrial ProteinsNeoplasm MetastasisNerve Tissue Proteinsrho GTP-Binding ProteinsVesicular Transport ProteinsKIF5B protein, humanKinesinsMembrane ProteinsMitochondrial ProteinsNerve Tissue Proteinsrho GTP-Binding ProteinsRHOT1 protein, humanRHOT2 protein, humanSNPH protein, humanVesicular Transport Proteins

Identifiers

PMID27991488
PMCPMC5187409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.